Skip to main content
. 2018 Oct 29;19:588. doi: 10.1186/s13063-018-2965-0

Table 2.

Patient demographics and hip characteristics

Treatment X
n =
Treatment Y
n =
Patient characteristics
 Age, mean (SD)
 Gender, n (%)
  Male
  Female
 Ethnicity, n (%)
  Native
  Asian
  Black
  Hispanic
  White/Caucasian
 Smoking history, n (%)
  Never smoked
  Current smoker
  Former smoker
 Alcohol consumption, n (%)
  No alcohol at baseline
  0.5–2 drinks/week
  3–5 drinks/week
  6–10 drinks/week
  11+ drinks/week
 Current medications, n (%)
  None
  NSAIDS
  Intra-articular injection
  Etc…. (as per available data)
 Co-morbidities, n (%)
  None
  Cancer
  Back pain
  Etc… (as per available data)
 BMI, n (%)
  Underweight < 18.5
  Normal weight 18.5–24.9
  Overweight 25–29.9
  Obese 30–39.9
  Morbidly obese 40 or greater
 Weightbearing status, n (%)
  Full weightbearing
  Partial weightbearing
  Non-weightbearing
 Baseline sport activity, n (%)
  None
  Light
  Moderate
  Vigorous
Hip characteristics
 Affected hip, n (%)
  Left
  Right
 Location of hip pain, n (%)
  Groin
  Lateral
  Posterior
  Groin and lateral
  Groin and posterior
  Lateral and posterior
  Groin and lateral and posterior
 Onset of symptoms, n (%)
  Acute
  Subacute
  Insidious
  Traumatic
  Non-traumatic
 Tonnis and Heinecke classification, n (%)
  Grade 0
  Grade 1
  Grade 2
  Grade 3
 Labral tears present, n (%)
  None
  Anterior
  Posterior
  Superior/lateral
  Anterior and posterior
  Anterior and superior/lateral
  Posterior and superior/lateral
 Herniation pits present, n (%)
  No
  Yes

NSAID non-steroidal anti-inflammatory drug, BMI body mass index